Cara Therapeutics | CARA - Trade Debtors

Stock Price
3.93
Daily Change
-0.09 -2.24%
Monthly
2.88%
Yearly
-73.37%
Q1 Forecast
3.87

Cara Therapeutics reported $2.24M in Trade Debtors for its fiscal quarter ending in March of 2025.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 148.23M 8.79M Dec/2025
Alterity Therapeutics Limited AUD 8.67M 1.59M Jun/2023
Assertio Holdings USD 39.91M 2.7M Jun/2024
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Cassava Sciences USD 817K 18K Sep/2025
Chugai Pharma JPY 443.11B 89.26B Dec/2025
Cipla INR 74.61B 19.39B Sep/2025
Clal Biotechnology ILS 3.75M 186K Dec/2022
Compugen USD 2.83M 930K Sep/2025
CSL USD 4.32B 1.35B Dec/2025
Grifols EUR 1.29B 83.03M Sep/2025
Halozyme Therapeutics USD 441.27M 95.24M Dec/2025
J&J USD 17.61B 235M Sep/2025
Neurocrine Biosciences USD 686.8M 41.2M Dec/2025
Pacira USD 124.07M 8.8M Dec/2025
Pfizer USD 18.12B 2.02B Sep/2025
RedHill Biopharma USD 5.35M 1.78M Jun/2025
Supernus Pharmaceuticals USD 187.8M 16.55M Dec/2025
Vanda Pharmaceuticals USD 47.1M 4.35M Dec/2024